X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (80) 80
infectious diseases (58) 58
male (58) 58
adult (55) 55
index medicus (55) 55
female (52) 52
middle aged (51) 51
hiv (49) 49
immunology (34) 34
life sciences (32) 32
hiv infections - drug therapy (31) 31
hiv infections - complications (28) 28
virology (28) 28
human-immunodeficiency-virus (25) 25
risk factors (24) 24
hepatitis c (23) 23
human immunodeficiency virus--hiv (23) 23
prospective studies (20) 20
hepatitis (19) 19
health aspects (18) 18
hepatitis c virus (18) 18
santé publique et épidémiologie (18) 18
aged (17) 17
france (17) 17
gastroenterology & hepatology (17) 17
antiviral agents - therapeutic use (16) 16
microbiology (16) 16
highly active antiretroviral therapy (15) 15
treatment outcome (15) 15
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (14) 14
aids (14) 14
antiretroviral therapy, highly active (14) 14
cohort studies (14) 14
france - epidemiology (14) 14
mortality (14) 14
antiretroviral therapy (13) 13
hiv infection (13) 13
protease inhibitors (13) 13
virus diseases (13) 13
drug therapy (12) 12
hepatitis c, chronic - complications (12) 12
human health and pathology (12) 12
patients (12) 12
viral load (12) 12
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (11) 11
analysis (11) 11
anti-hiv agents - therapeutic use (11) 11
drug therapy, combination (11) 11
hiv infections - virology (11) 11
hiv patients (11) 11
hiv-1 (11) 11
infection (11) 11
aids/hiv (10) 10
coinfected patients (10) 10
coinfection (10) 10
hepatitis c - complications (10) 10
hepatitis c - drug therapy (10) 10
infections (10) 10
ribavirin (10) 10
surveys and questionnaires (10) 10
therapy (10) 10
viruses (10) 10
follow-up studies (9) 9
hiv infections - epidemiology (9) 9
prevalence (9) 9
safety (9) 9
anti-hiv agents - adverse effects (8) 8
antiretroviral drugs (8) 8
antiviral agents (8) 8
care and treatment (8) 8
chronic hepatitis-c (8) 8
cirrhosis (8) 8
coffee (8) 8
cohort (8) 8
disease (8) 8
fibrosis (8) 8
hepatitis c, chronic - drug therapy (8) 8
liver (8) 8
medical research (8) 8
medicine, general & internal (8) 8
prognosis (8) 8
active antiretroviral therapy (7) 7
antiviral agents - adverse effects (7) 7
comorbidity (7) 7
disease progression (7) 7
dosage and administration (7) 7
efficacy (7) 7
epidemiology (7) 7
hiv infections - immunology (7) 7
infected patients (7) 7
multivariate analysis (7) 7
research (7) 7
ribavirin - therapeutic use (7) 7
risk (7) 7
adolescent (6) 6
aids vaccines - immunology (6) 6
cannabis (6) 6
cd4 lymphocyte count (6) 6
coinfection - drug therapy (6) 6
genotype (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Addiction, ISSN 0965-2140, 09/2017, Volume 112, Issue 9, pp. 1669 - 1679
Journal Article
Drug and Alcohol Review, ISSN 0959-5236, 03/2017, Volume 36, Issue 2, pp. 227 - 238
Journal Article
by Gelu‐Simeon, Moana and Lewin, Maïté and Ostos, Maria and Bayan, Tatiana and Beso Delgado, Maria and Teicher, Elina and Layese, Richard and Roudot‐Thoraval, Françoise and Fontaine, Hélène and Sobesky, Rodolphe and Salmon‐Céron, Dominique and Samuel, Didier and Seror, Olivier and Nahon, Pierre and Meyer, Laurence and Duclos‐Vallée, Jean‐Charles and Petrov‐Sanchez, Ventzislava and Autran, Brigitte and Boufassa, Faroudy and Bourlière, Marc and Dominguez, Stéphanie and Hézode, Christophe and Pageaux, Georges‐Philippe and Poizot‐Martin, Isabelle and Roque‐Afonso, Anne‐Marie and Samri, Assia and Vittecoq, Daniel and Dabis, F and Winnock, M and Loko, A and Sogni, P and Benhamou, Y and Trimoulet, P and Izopet, J and Paradis, V and Spire, B and Carrieri, P and Katlama, C and Pialoux, G and Valantin, A and Bonnard, P and Poizot‐Martin, I and Marchou, B and Rosenthal, E and Garipuy, D and Bouchaud, O and Gervais, A and Lascoux‐Combe, C and Goujard, C and Lacombe, K and Duvivier, C and Vittecoq, D and Neau, D and Morlat, P and BaniSadr, F and Boufassa, F and Dominguez, S and Autran, B and Roque, M and Solas, C and Serfaty, L and Chêne, G and Costagliola, D and Zucman, D and Simon, A and Dominguez, S and Billaud, E and Miailhes, P and Devoto, J and Couffin‐Cadiergues, S and Nahon, P and Mahuas‐Bourcier, V and Zucman‐Rossi, J and Bedossa, P and Laurent, A and Layese, R and Durand‐Zaleski, I and Marche, P and Thibault, V and Guyader, D and Dharancy, S and Leroy, V and Vilgrain, V and Bonjour, M and Cagnot, C and Petrov‐Sanchez, V and ANRS CO13 HepaVih Study Grp and ANRS CO12 CirVir Study Grp and ANRS HC EP 25 Prethevic Study Grp and ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups and the ANRS HC EP 25 Prethevic, ANRS CO13 HepaVih and ANRS CO12 CirVir Study Groups
Liver International, ISSN 1478-3223, 01/2019, Volume 39, Issue 1, pp. 136 - 146
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2011, Volume 70, Issue 4, pp. 616 - 623
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2009, Volume 50, Issue 4, pp. 736 - 745
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2007, Volume 44, Issue 11, pp. 1484 - 1492
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, pp. e0199874 - e0199874
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 07/2009, Volume 65, Issue 7, pp. 667 - 678
To assess the relationship between genetic polymorphisms and indinavir pharmacokinetic variability and to study the link between concentrations and short-term... 
Efficacy | Safety | Protease inhibitors | CYP3A4 | Nonlinear mixed effects modeling | Pharmacokinetics | GENETIC POLYMORPHISMS | HIV-1-INFECTED PATIENTS | HUMAN-IMMUNODEFICIENCY-VIRUS | CLINICAL PHARMACOKINETICS | CYTOCHROME-P450 3A4 | ALPHA-ACID GLYCOPROTEIN | POPULATION PHARMACOKINETICS | ACTIVE ANTIRETROVIRAL THERAPY | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | HIV-1 | Prospective Studies | Area Under Curve | Humans | Middle Aged | Male | Metabolic Clearance Rate | Multicenter Studies as Topic | HIV Protease Inhibitors - pharmacokinetics | Adult | Female | Cytochrome P-450 CYP3A - drug effects | HIV Protease Inhibitors - adverse effects | Indinavir - pharmacokinetics | Pharmacogenetics | Anti-HIV Agents - adverse effects | Genotype | Treatment Outcome | Clinical Trials as Topic | Models, Statistical | Polymorphism, Genetic | Antiretroviral Therapy, Highly Active | Pilot Projects | Anti-HIV Agents - pharmacokinetics | HIV Infections - drug therapy | Indinavir - adverse effects | Cohort Studies | Highly active antiretroviral therapy | Algorithms | RNA | Proteases | Analysis | Cytochrome P-450 | HIV patients | Models | Triglycerides | HIV (Viruses) | Indinavir | Antiretroviral drugs | Genotype & phenotype | Human immunodeficiency virus--HIV | Patient safety | Pharmacology | Drug therapy | Polymorphism | Index Medicus | HIV Infections | Cytochrome P-450 CYP3A | Nonlinear Mixed Effects Modeling | pharmacokinetics | drug therapy | drug effects | Anti-HIV Agents | HIV Protease Inhibitors | adverse effects
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 12/2019, Volume 31, Issue 12, pp. 1508 - 1517
OBJECTIVESAlthough common among patients coinfected with HIV and hepatitis C virus (HCV), sleep disturbances (SD) are still poorly documented in this... 
Life Sciences | Human health and pathology | Santé publique et épidémiologie | Hépatology and Gastroenterology | Infectious diseases
Journal Article